SCFβ-TRCP suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2

Shavali Shaik(Brigham and Women's Hospital), Wenyi Wei(Beth Israel Deaconess Medical Center)
The Journal of Experimental Medicine
June 18, 2012
Cited by 94


Related Papers